Inventor · disambiguated record
Stefan Barghorn
Also filed as: BARGHORN STEFAN
17 granted patents·15 pending applications·87 citations·filing 2006–2022
93Inventor score
Top patents by PatentIndex Score
32 records- 0190US8987419B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Mar 24, 2015·15 cites·11 claims
- 0290US8691224B2Anti-Aβ globulomer 5F7 antibodiesBARGHORN STEFAN·Filed 2006·Granted Apr 8, 2014·14 cites·16 claims
- 0388US8263558B2Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteinsHOLZMAN THOMAS F·Filed 2006·Granted Sep 11, 2012·23 cites·14 claims
- 0487US9359430B2Abeta conformer selective anti-Abeta globulomer monoclonal antibodiesABBVIE INC·Filed 2013·Granted Jun 7, 2016·4 cites·7 claims
- 0586US9394360B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 19, 2016·6 cites·2 claims
- 0685US10323084B2Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2017·Granted Jun 18, 2019·3 cites·16 claims
- 0785US8497072B2Amyloid-beta globulomer antibodiesHILLEN HEINZ·Filed 2006·Granted Jul 30, 2013·6 cites·18 claims
- 0883US9062101B2Amyloid-beta binding proteinsBARGHORN STEFAN·Filed 2011·Granted Jun 23, 2015·6 cites·43 claims
- 0980US8455626B2Aβ conformer selective anti-aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2007·Granted Jun 4, 2013·4 cites·13 claims
- 1077US10047121B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Aug 14, 2018·2 cites·18 claims
- 1176US2022017607A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2021·Application pending·0 cites
- 1275US9951125B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesABBVIE INC·Filed 2016·Granted Apr 24, 2018·1 cites·19 claims
- 1374US10538581B2Anti-Aβ globulomer 4D10 antibodiesABBVIE INC·Filed 2016·Granted Jan 21, 2020·1 cites·17 claims
- 1471US2022018855A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 1570US8895004B2Method for the treatment of amyloidosesNIMMRICH VOLKER·Filed 2008·Granted Nov 25, 2014·2 cites·3 claims
- 1669US2024075114A1IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2022·Application pending·0 cites
- 1764US2015071915A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 1859US9540432B2Anti-Aβ globulomer 7C6 antibodiesABBVIE INC·Filed 2013·Granted Jan 10, 2017·0 cites·14 claims
- 1959US2020241012A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 2058US10208109B2Monoclonal antibodies against amyloid beta protein and uses thereofHILLEN HEINZ·Filed 2011·Granted Feb 19, 2019·0 cites·20 claims
- 2158US2016159891A1Monoclonal antibodies against amyloid beta protein and uses thereofABBVIE INC·Filed 2016·Application pending·0 cites
- 2257US8877190B2Aβ conformer selective anti-Aβ globulomer monoclonal antibodiesBARGHORN STEFAN·Filed 2011·Granted Nov 4, 2014·0 cites·5 claims
- 2353US2018094049A1Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2452US2010173828A1Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereofABBOTT GMBH & CO KG·Filed 2009·Application pending·0 cites
- 2550US9822171B2Amyloid-beta binding proteinsABBVIE DEUTSCHLAND·Filed 2015·Granted Nov 21, 2017·0 cites·15 claims
- 2649US2011092445A1Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their usesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2749US2009175847A1Humanized antibodies to ab (20-42) globulomer and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 2849US2009232801A1Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses ThereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 2948US2016069907A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 3044US2015079096A1Method for the treatment of amyloidosesABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3143US2009035295A1Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said AntibodiesABBOTT GMGH & CO KG·Filed 2006·Application pending·0 cites
- 3241US2016000891A1IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →